These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1679947)

  • 1. Enhancement of interleukin 2 production in human and Gibbon T cells after in vitro treatment with lithium.
    Wu YY; Yang XH
    Proc Soc Exp Biol Med; 1991 Oct; 198(1):620-4. PubMed ID: 1679947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
    Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
    Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production.
    Van der Pouw-Kraan T; Van Kooten C; Rensink I; Aarden L
    Eur J Immunol; 1992 May; 22(5):1237-41. PubMed ID: 1349533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell activation via the T cell receptor: a comparison between WT31 (defining alpha/beta TcR)-induced and anti-CD3-induced activation of human T lymphocytes.
    Gupta S; Shimizu M; Ohira K; Vayuvegula B
    Cell Immunol; 1991 Jan; 132(1):26-44. PubMed ID: 1829655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation between early and late events in T cell activation mediated through CD28 surface molecule.
    Nunes J; Bagnasco M; Lopez M; Lipcey C; Mawas C; Olive D
    Mol Immunol; 1991; 28(4-5):427-35. PubMed ID: 1648171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of interleukin-2 production in CD4+ and CD8+ T-cell subsets after activation via CD3 and CD2.
    Halvorsen R; Leivestad T; Gaudernack G; Thorsby E
    Scand J Immunol; 1988 Oct; 28(4):449-55. PubMed ID: 2904172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
    J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of phorbol ester-induced T cell proliferation by agents which raise intracellular cyclic adenosine monophosphate.
    Chakkalath HR; Jung LK
    Cell Immunol; 1992 Dec; 145(2):240-53. PubMed ID: 1333364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of functional GTP binding proteins in Jurkat T cell mutants lacking either CD3-Ti or CD2 surface receptors.
    Moingeon P; Jin YJ; Stebbins CC; Lopez PA; Alcover A; Reinherz EL
    Cell Immunol; 1990 Jul; 128(2):578-88. PubMed ID: 1972660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the 3',5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells.
    Wacholtz MC; Minakuchi R; Lipsky PE
    Cell Immunol; 1991 Jul; 135(2):285-98. PubMed ID: 1709824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody.
    Bertotto A; Gerli R; Lanfrancone L; Crupi S; Arcangeli C; Cernetti C; Spinozzi F; Rambotti P
    Cell Immunol; 1990 May; 127(2):247-59. PubMed ID: 2139363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3-dependent increase in cyclic AMP in human T-cells following stimulation of the CD2 receptor.
    Kvanta A; Jondal M; Fredholm BB
    Biochim Biophys Acta; 1991 Jul; 1093(2-3):178-83. PubMed ID: 1677813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of an active surface CD2 by DNA transfer in CD2-CD3+ Jurkat cells facilitates CD3-T cell receptor-mediated IL-2 production.
    Makni H; Malter JS; Reed JC; Nobuhiko S; Lang G; Kioussis D; Trinchieri G; Kamoun M
    J Immunol; 1991 Apr; 146(8):2522-9. PubMed ID: 1707910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS; Boltz RC; Siekierka JJ; Sigal NH
    Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
    Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
    J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation.
    Stohl W; Crow MK
    Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3Ti+ human thymocyte-derived clones displaying a differential response to activation via CD3Ti and CD2.
    Testi R; Alcover A; Spagnoli G; Reinherz EL; Acuto O
    Cell Immunol; 1989 Sep; 122(2):350-64. PubMed ID: 2569934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin modulates the T cell antigen receptor/CD3 complex but not the CD2 molecule and inhibits signaling via both receptor structures in the human T cell lymphoma Jurkat.
    Sommermeyer H; Schwinzer R; Kaever V; Wessel K; Schmidt RE; Behl B; Wonigeit K; Szamel M; Resch K
    Eur J Immunol; 1989 Dec; 19(12):2387-90. PubMed ID: 2575034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.